Hopkins and his colleagues recruited 36 women with a history of recurrent infections – an average of six or seven infections per year. Some women received the vaccine, while others received a placebo.S. Grant Mulholland, MD, head of the Department of Urology at Thomas Jefferson University in Philadelphia, tells WebMD that the vaccine, or a similar product, is a useful tool in the fight against new infections, recurrent urinary tract. He said that the current approach to vaccination is the wave of the future. ‘What we will see in the next decade [are] new ways to treat infections directly without trying to kill them with antibiotics as we do now,’ he said.
After three weekly applications of the vaccine, which is used only once a month. ‘We think it will be easier for women to use – just assumed every month,’ study author Walter J. Hopkins, PhD, tells WebMD.
Aging does not necessarily mean getting old. Subscribe to the newsletter today WebMD popular women’s health for tips on aging gracefully.
Thousands of women suffer each year from these recurrent infections, which are infections of the bladder. This is an infection characterized by unpleasant and sometimes painful burning or pain during urination, frequent urination, sudden urge to urinate, urgent, or feeling of pressure or pain in lower back and abdomen. Sometimes, women may also have fever, strong smell of urine or blood in the urine.
Previous attempts to develop a vaccine to prevent these infections have been a failure. These vaccines, when administered once, has had many side effects. This vaccine, as it is applied directly to the source of the problem, avoid these reactions, and is intended to provide protection where you need it most.
One day soon, women who suffer from painful recurrent infections of the urinary tract may be able to exchange antibiotics for a vaccine. Supposedly new vaccine applied directly to the vagina promises to reduce the number of times these women have infections and endure the unwanted side effects of antibiotic therapy to treat the infection. This is according to preliminary results of a study reported here Saturday at an annual meeting of urologists.
To date, nearly 100 women have received the vaccine in early studies, and none had significant side effects. Less than 5percent of treated women experienced vaginal irritation or short. The vaccine targets the bacteria that cause urinary tract infections alone. It does not protect against other vaginal infections, such as.